Description
Research Purposes Only
CJC-1295 & Ipamorelin (CJC/IPA) is a combined peptide formulation studied for its role in stimulating natural growth hormone release through complementary pathways. CJC-1295, a growth hormone–releasing hormone (GHRH) analogue, works alongside Ipamorelin, a selective growth hormone secretagogue, to support pulsatile GH release while maintaining a controlled and targeted profile. In research settings, this combination is commonly associated with recovery, sleep quality, tissue repair, and body composition optimisation, making it a well-recognised pairing in performance-focused protocols.
A combined peptide formulation associated with growth hormone stimulation pathways.
Designed for recovery, performance, and body composition support.
